|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review
1 Laboratory of Genetic and Molecular Cardiology, Science and Technology Pole, Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milan, Italy
2 Institute of Biomedical Technologies, Italian National Research Council (CNR), Milan, Italy
3 Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, California
MicroRNA has been shown to be essential for correct cardiovascular development and physiology in a number of recent reports. Studies have also started to characterize the link between specific microRNAs and aspects of pathogenesis—such as chamber morphogenesis, conduction, and contraction—and between microRNA expression signatures and pathological cardiac phenotypes—such as hypertrophy, ischemic cardiomyopathy, dilated cardiomyopathy, and aortic stenosis. Congenital anomalies of the heart may also be associated with the dysregulation of specific microRNAs. Here we report on the latest findings.
hypertrophy; cardiomyopathy; cardiac insufficiency
This article has been cited by other articles:
![]() |
P. Alexiou, T. Vergoulis, M. Gleditzsch, G. Prekas, T. Dalamagas, M. Megraw, I. Grosse, T. Sellis, and A. G. Hatzigeorgiou miRGen 2.0: a database of microRNA genomic information and regulation Nucleic Acids Res., November 17, 2009; (2009) gkp888v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang, Y. Liu, D. Mladinov, A. W. Cowley Jr., H. Trivedi, Y. Fang, X. Xu, X. Ding, and Z. Tian MicroRNA: a new frontier in kidney and blood pressure research Am J Physiol Renal Physiol, September 1, 2009; 297(3): F553 - F558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang MicroRNA: a new entrance to the broad paradigm of systems molecular medicine Physiol Genomics, July 9, 2009; 38(2): 113 - 115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |